PT - JOURNAL ARTICLE AU - Landaverde, Lena AU - McIntyre, David AU - Robson, James AU - Fu, Dany AU - Ortiz, Luis AU - Chen, Rita AU - Oliveira, Samuel M.D. AU - Fan, Andy AU - Barrett, Amy AU - Burgay, Stephen P. AU - Choate, Stephen AU - Corbett, David AU - Doucette-Stamm, Lynn AU - Gonzalez, Kevin AU - Hamer, Davidson H. AU - Huang, Lilly AU - Huval, Shari AU - Knight, Christopher AU - Lindquist, Diane AU - Lockard, Kelly AU - Macdowell, Trevor L. AU - Mauro, Elizabeth AU - McGinty, Colleen AU - Miller, Candice AU - Monahan, Maura AU - Moore, Randall AU - Platt, Judy AU - Roy, Jeffrey AU - Schroeder, Tracey AU - Tolan, Dean R. AU - Zaia, Ann AU - Brown, Robert A. AU - Waters, Gloria AU - Densmore, Douglas AU - Klapperich, Catherine M. TI - Detailed Overview of the Buildout and Integration of an Automated High-Throughput CLIA Laboratory for SARS-CoV-2 Testing on a Large Urban Campus AID - 10.1101/2021.09.13.21263214 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.13.21263214 4099 - http://medrxiv.org/content/early/2021/09/16/2021.09.13.21263214.short 4100 - http://medrxiv.org/content/early/2021/09/16/2021.09.13.21263214.full AB - In 2019, the first cases of SARS-CoV-2 were detected in Wuhan, China, and by early 2020 the cases were identified in the United States. SARS-CoV-2 infections increased in the US causing many states to implement stay-at-home orders and additional safety precautions to mitigate potential outbreaks. As policies changed throughout the pandemic and restrictions lifted, there was an increase in demand for Covid-19 testing which was costly, difficult to obtain, or had long turn-around times. Some academic institutions, including Boston University, created an on-campus Covid-19 screening protocol as part of planning for the safe return of students, faculty, and staff to campus with the option for in-person classes. At BU, we stood up an automated high-throughput clinical testing lab with the capacity to run 45,000 individual tests weekly by fall of 2020, with a purpose-built clinical testing laboratory, a multiplexed RT-PCR test, robotic instrumentation, and trained CLIA certified staff. There were challenges to overcome, including the supply chain issues for PPE testing materials, and equipment that were in high demand. The Boston University Clinical Testing Laboratory was operational at the start of the fall 2020 academic year. The lab performed over 1 million SARS-CoV-2 RT-PCR tests during the 2020-2021 academic year.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was used for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CLIA is the oversight body for clinical testing laboratories. We adhere to all CLIA requirements.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request.